Neuroglia in leukodystrophies

Publication date

2025-03-25

Authors

Hol, EllyORCID 0000-0001-5604-2603
Dykstra, Werner
Chevalier, Juliette
Cuadrado, Eloy
Bugiani, Marianna
Aronica, E.ISNI 0000000394511743
Verkhratsky, Alexei

Editors

Advisors

Supervisors

Document Type

Part of book

Collections

Open Access logo

License

taverne

Abstract

Leukodystrophies are a heterogeneous group of rare genetic neurologic disorders characterized by white matter degeneration resulting from mutations affecting glial cells. This review focuses on the primary subtypes-astroglial, oligodendroglial, and microglial leukodystrophies-offering a detailed description of their neuropathologic features and clinical manifestations. It delves into key aspects of the pathogenesis, emphasizing the distinct cellular mechanisms that drive white matter damage. Advances in disease modeling, including the development of animal models with pathologic gene expressions and patient-derived iPS-cell models, have significantly enhanced our understanding of these rare disorders. Insights into the roles of different glial cell types highlight the complexity of leukodystrophies and provide a foundation for the development of targeted therapeutic strategies.

Keywords

Aicardi–Goutières syndrome, Alexander disease, Astroglial leukodystrophies, Canavan disease, Krabbe disease, Microglial leukodystrophies, Nasu–Hakola disease, Oligodendroglial leukodystrophies, Pelizaeus–Merzbacher disease, Vanishing white matter disease, Taverne, Neurology, Clinical Neurology

Citation

Hol, E M, Dykstra, W, Chevalier, J, Cuadrado, E, Bugiani, M, Aronica, E & Verkhratsky, A 2025, Neuroglia in leukodystrophies. in Handbook of Clinical Neurology. Handbook of Clinical Neurology, vol. 210, Elsevier, pp. 159-175. https://doi.org/10.1016/B978-0-443-19102-2.00032-6